-
RENA LIU
Counsel·Shanghai
PROFILE REPRESENTATIVE MATTERS AND CASES OTHER INFORMATION Further Reading
MS. LIU SPECIALIZES IN M&A, PRIVATE EQUITY, JOINT VENTURES, CROSS-BORDER TRANSACTIONS, FINANCE, ASSET MANAGEMENT, REGULATORY AND COMPLIANCE, AND GENERAL CORPORATE MATTERS.
Education
University of Virginia, J.D. (2016)
University of North Carolina – Chapel Hill, B.A. (2013)
Professional Qualification
Admitted to practice in the PRC
Admitted to practice in the State of New York
Professional Background
Ms. Liu joined Fangda in 2020. Before joining the firm, she worked in a leading US law firm and a leading British law firm.
PROFILE
REPRESENTATIVE MATTERS AND CASES
- Advising JPMorgan on its minority investment in CMB Wealth Management, a wholly owned asset management subsidiary of China Merchants Bank
- Advising JPMorgan on its 100% acquisition of the equity interest in China International Fund Management
- Advising a leading European wealth management group on forming a joint venture securities company
- Advising a leading US wealth management group on its minority investment in the wholly owned asset management subsidiary of a commercial bank
- Advising a leading US investment management group on forming a joint venture investment consulting company
- Advised Blackstone and other leading foreign asset managers on their applications for the Qualified Foreign Institutional Investor (QFII) license and provided legal advice to the QFII operation
- Advised JPMorgan on its minority investment in Shanghai Kingstar Fintech
- Advised an Asian SWF on a Cayman-domiciled core logistics fund’s acquisition of a portfolio of logistics real properties in China from JD Logistics
- Advised a European technology company on its investment in a Chinese company in the intelligent diagnostics industry
- Advised EDF Renewables, an EDF Group subsidiary dedicated to renewable energy, on the acquisition of a majority stake in a portfolio of 77 MWp rooftop PV assets from Asia Clean Capital to build and operate a portfolio of distributed rooftop solar projects in China
- Advised an international client on acquiring and servicing portfolios of nonperforming loans (NPLs)
- Advised Cardinal Health on its USD 1.2 billion sale of its China business to Shanghai Pharmaceuticals Holding
